C4 Therapeutics develops drugs that remove disease-causing proteins from cells, with candidates in cancer and inflammation. It last closed at $2.53 on Nov 17, down 4.53% on the day. The average 12-month price target from 3 analysts is $9.00 (+255.7% from the last close), with a high of $11.00 and a low of $6.00. Analyst consensus is Strong Buy, based on the latest ratings from 3 firms (3 buy, 0 hold, 0 sell). In the past 30 days there were 3 dark pool prints totaling $716K, the largest $245K.
Each firm's latest rating on CCCC in the past 90 days
Average 12-month target
$9.00
▲ 255.7% upside
Based on 3 analysts who set a price target on CCCC in the past 90 days. The average target is $9.00, with a high of $11.00 and a low of $6.00, compared with the last close of $2.53.
Low $6.00Avg $9.00High $11.00
Blue marker: last close $2.53
Highest target$11.00
Average target$9.00
Lowest target$6.00
Latest rating changes
GuggenheimMaintained
Nov 6Buy$6
Lake StreetInitiated
Oct 28Buy$11
JP MorganInitiated
Oct 9Buy$10
Evercore ISI GroupMaintained
Jun 1Buy$12
Date
Firm
Action
Rating
Price target
Nov 6
Guggenheim
Maintained
Buy
$6
Oct 28
Lake Street
Initiated
Buy
$11
Oct 9
JP Morgan
Initiated
Buy
$10
Jun 1
Evercore ISI Group
Maintained
Buy
$12
Loading…
Technical Analysis
CCCC · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold
The stock is 21% below its 20 day and 22% below its 50 day average. It is 29% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 33), near oversold. The nearest support is the Pivot at $2.52, and the nearest resistance the Pivot R1 at $2.67.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityNormal, 9.0%/day
Key levels
$5.1752 week high+104.3%
$3.49100 day average+37.9%
$3.26200 day average+28.9%
$3.25Swing high (Oct 22)+28.5%
$3.0950 day average+22.1%
$3.0520 day average+20.6%
$2.67Pivot R1+5.5%
$2.53Last close
$2.52Pivot−0.4%
$2.39Pivot S1−5.5%
$1.6952 week low−33.2%
Indicators
RSI (14)
33.44
Weak, oversold below 30
Neutral
MACD
-0.12
Below its signal line
Bearish
Stochastic
11.2
Near the bottom of its range
Oversold
ADX (14)
18.2
No clear trend
Williams %R
-85.8
Oversold below −80, overbought above −20
Oversold
CCI (20)
-198.4
Oversold below −100, overbought above 100
Oversold
Rate of change
−21.2%
Change over 10 sessions
Bearish
ATR (14)
$0.23
Typical daily range, 8.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Falling
Short trendBearish
Long trendNot enough history
MomentumWeak
StretchNormal
VolatilityNormal, 21.2%/day
Key levels
$5.1752 week high+104.3%
$3.49100 day average+37.9%
$3.26200 day average+28.9%
$3.25Swing high (Oct 22)+28.5%
$3.0950 day average+22.1%
$3.0520 day average+20.6%
$2.67Pivot R1+5.5%
$2.53Last close
$2.52Pivot−0.4%
$2.39Pivot S1−5.5%
$1.6952 week low−33.2%
Indicators
RSI (14)
39.34
Weak, oversold below 30
Neutral
MACD
-0.14
Below its signal line
Bearish
Stochastic
15.2
Near the bottom of its range
Oversold
ADX (14)
21.1
Weak trend
Williams %R
-92.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-151.5
Oversold below −100, overbought above 100
Oversold
Rate of change
−27.9%
Change over 10 sessions
Bearish
ATR (14)
$0.54
Typical daily range, 21.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200–
What happened before, for CCCC
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CCCC did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow CCCC usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CCCC has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CCCC is in one of them and how their past CCCC trades turned out.
C4 Therapeutics is a biopharmaceutical company based in Watertown, Massachusetts. It develops medicines based on targeted protein degradation, a process that removes disease-causing proteins from cells. Its most advanced drug candidates are being tested in cancers, including multiple myeloma and lung cancer, and it is also building programs for inflammation and neurological diseases. The company works with partners such as Merck KGaA, Roche and Pfizer on drug discovery and development.